White House says J&J COVID-19 shot shipments to be low until U.S. vaccine plant cleared by regulators
White House says J&J COVID-19 shot shipments to be low until U.S. vaccine plant cleared by regulators
J&J is working closely with regulators to resolve the issues holding up authorization, said Jeff Zients, the White House's COVID-19 response coordinator. It expects to start shipping 8 million doses per week towards the end of April and remains on track to deliver around 100 million shots by the end of May, he added.
(Reporting by Carl O'Donnell)
((Carl.ODonnell@thomsonreuters.com; 646-223-6629;)
April 9 (Reuters) - Johnson & Johnson will ship relatively few COVID-19 shots around the United States until it receives regulatory clearance for a large vaccine plant in Baltimore that has struggled to meet quality control standards, a top White House Health official said on a Friday press conference.
J&J is working closely with regulators to resolve the issues holding up authorization, said Jeff Zients, the White House's COVID-19 response coordinator. It expects to start shipping 8 million doses per week towards the end of April and remains on track to deliver around 100 million shots by the end of May, he added.
(Reporting by Carl O'Donnell)
((Carl.ODonnell@thomsonreuters.com; 646-223-6629;)
路透4月9日电-白宫一位高级卫生官员在周五的新闻发布会上表示，在巴尔的摩一家大型疫苗厂获得监管批准之前，强生公司将在美国各地运送相对较少的新冠肺炎疫苗。该厂一直难以达到质量控制标准。白宫新冠肺炎回应协调员齐恩茨(Jeff Zients)说，强生正在与监管机构密切合作，以解决阻碍授权的问题。他补充说，该公司预计将在4月底开始每周运送800万剂疫苗，并保持在5月底之前交付约1亿剂疫苗的轨道上。(Carl O‘Donnell报道)(Carl.ODonnell@thomsonreurs.com；646-223-6629；)
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧